Skip to main content
TipRanks
Go Ultimate75% OFF

Newbury Pharmaceuticals AB (NEWBRY) Cash flow

0 Followers

Newbury Pharmaceuticals AB Cash Flow

SE:NEWBRY's free cash flow for Q2 2025 was kr-6.37M. For the 2025 fiscal year, SE:NEWBRY's free cash flow was increased by kr0.00 and operating cash flow was kr-6.37M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowAug 24Aug 23Aug 22Aug 21
kr -23.71Mkr -23.23Mkr -15.00Mkr -4.07M
kr -2.95Mkr -862.00Kkr -24.40Mkr -26.73M
kr 33.44Mkr -717.00Kkr 59.59Mkr 43.95M
kr 15.30Mkr 8.53Mkr 33.33Mkr 13.14M
kr -26.62Mkr -24.09Mkr -39.40Mkr -27.15M

Currency in SEK

Newbury Pharmaceuticals AB Cash Flow

-40M-20M020M40M60M80M2021202220232024OperatingInvestingFinancing